Search filters

List of works by Dena Howard

A platform trial in practice: adding a new experimental research arm to the ongoing confirmatory FLAIR trial in chronic lymphocytic leukaemia

scientific article published on 08 January 2021

A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia

scientific article published on 14 January 2011

Adding a treatment arm to an ongoing clinical trial: a review of methodology and practice

scientific article published on 22 April 2015

An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma

scientific article published on 15 June 2007

Analysis of VHL Gene Alterations and their Relationship to Clinical Parameters in Sporadic Conventional Renal Cell Carcinoma

scientific article published on December 2009

Characterizing and quantifying the effects of breast cancer therapy using mathematical modeling

scientific article published on 19 January 2016

Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials

scientific article published on 01 August 2019

Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation

scientific article published on 29 December 2016

Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer

scientific article published in February 2006

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

scientific article published on June 23, 2011

Proliferation index: a continuous model to predict prognosis in patients with tumours of the Ewing's sarcoma family

scientific article

Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL.

scientific article published on 24 March 2017

Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II study

scientific article